Abstract:Human cytomegalovirus (HCMV) glycoprotein complex II (gcII) consists of two glycoproteins, gM and gN. Although gcII specific IgG purified from HCMV positive patient sera can neutralize HCMV, there has been no report describing the generation of virus-neutralizing antibodies by immunization with individual recombinant gM or gN antigens. In the current study, gM and gN antigens were expressed by the mammalian expression vector pJW4303 and used as DNA vaccines to determine the immunogenicity of these proteins. Sera from mice or rabbits immunized with individual or combinations of gM and gN DNA vaccines contained gM and gN specific antibodies as confirmed by ELISA and Western blot analyses. The combined gM and gN antigens induced the strongest antibody responses that recognized both gM and gcII complex while gM DNA vaccine alone could only elicit antibody specific for gM antigen. When given alone, the gN DNA vaccine did not induce detectable gcII specific antibody even though in vitro gN expression was confirmed by the formation of gM/gN complex in FSK cells using a gN-specific monoclonal antibody 14-16A. The neutralizing antibody titer of anti-gM/gN sera (1:128) was higher than that of anti-gM sera (1:32) against the autologous virus, HCMV AD169. Heterologous HCMV strains including Towne and Davis could also be neutralized by the anti-gM/gN antisera. Our data supported the rationale for the use of the HCMV gM/gN protein complex as protective antigens for subunit based HCMV vaccine development. DNA vaccination is an effective approach to express the gM/gN antigen complex in vivo without the need to express and purify these highly insoluble and structurally complicated antigens.

Expression of human cytomegalovirus glycoprotein B epitope

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

Expression of Soluble H1N1 Haemegglutinin in Two Distinct Insect Baculovirus Expression Systems

Glycoprotein B Genotype of Human Cytomegalovirus Analysis by Npcr-Rflp

A Novel Polyclonal Antibody Against Human Cytomegalovirus: General Characteristics and Potential Application in Diagnosis

Prokaryotic Expression and Purification of Major Epitopes Domain of Herpes Simplex Virus Type 1 Glycoprotein D

Cloning of Hemagglutinin Gene of Edmonston Vaccine Strain of Measles Virus and Fusion Protein Expression in Escherichia Coli

Preclinical Evaluations of Peptide-Conjugate Vaccines Targeting the Antigenic Domain-2 of Glycoprotein B of Human Cytomegalovirus.

Study on B-cell epitopes of glycoprotein L expressed by human cytomegalovirus UL115 gene of AD169 strain

[Cloning and Expression of HSV-I, II Type-Common Antigen Gd in Escherichia Coli].

Rapid and sensitive identification of glycoprotein h genotypes in clinical human cytomegalovirus samples.

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Prokaryotic Expression of Structural Domains of the Newcastle Disease Virus Hemagglutinin-Neuraminidase

Expression and Purification of the DNA Binding Domain of the Epstein-Barr Virus Nuclear Antigen 1

Study on B-cell Epitopes of Protein Expressed by Human Cytomegalovirus Gene UL144 Open Reading Frame

Expression and Application of Synthetic Gene of Lymphocytic Choriomeningitis Virus Nucleoprotein

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

DNA Vaccines Expressing Glycoprotein Complex II Antigens Gm and Gn Elicited Neutralizing Antibodies Against Multiple Human Cytomegalovirus (HCMV) Isolates.

Identification and Analysis of B Cell Epitopes of Hemagglutinin of H1N1 Influenza Virus.

Novel Potent Neutralizing Antibodies Revealed the Domain I of HCMV Glycoprotein B for Vaccine Design

Expression and Immunogenicity of the Eukaryotic Vector of Mimotope Mgc Derived from Glycoprotein C of Herpes Simplex Virus